Constipation ( K59.0 plus Y42.3) is reported in approximately 68% of patients, while dyspepsia ( K30 plus Y42.3) and abdominal pain ( R10.4 for unspecified abdominal pain, plus Y42.3) are also documented
GLP-based treatments may support healthier metabolic function, improved insulin sensitivity, reduced inflammation, digestive health, and long-term wellness goals
Copper peptides support barrier function rather than disrupting it, making them potentially gentler than many other active ingredients
SUPPLEMENT:Acetyl L-Carnitine
For some people, being on a GLP-1 may translate into a lower food budget, as they spend less at the grocery store, eat less at restaurants, or have an alcoholic beverage less often than usual